Research News

Evolocumab “must become cheaper” to be cost effective in enhancing benefits of statins

BMJ 2017; 358 doi: https://doi.org/10.1136/bmj.j4042 (Published 30 August 2017) Cite this as: BMJ 2017;358:j4042

You do not have access to the full text of this article, the first page of the PDF of this article appears below.

PDF extract preview

Sign in

Log in through your institution

Subscribe